Related Experiment Video
Updated: Sep 12, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Clinical Characteristics, Imaging Patterns and Management in Male and Female Patients with Primary Sjögren's
Guanning Zhong1, Congcong Zhang1, Weiwei Xie1
1Department of Pulmonary and Critical Care Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
Introduction:
The influence of sex on primary Sjögren's disease-associated interstitial lung disease (pSjD-ILD) remains poorly understood. Therefore, we aimed to investigate the sex-related differences in the clinical characteristics and outcomes of pSjD-ILD.
Methods:
Consecutive patients with pSjD-ILD in Nanjing University Affiliated Drum Tower Hospital from November 2007 to November 2022 were enrolled. Demographics, comorbidities, laboratory parameters, imaging patterns, pulmonary function tests, and treatments were compared between male and female patients. Kaplan-Meier method was used to assess survival. Cox proportional hazards model was employed to identify prognostic factors.
Results:
A total of 125 male and 433 female patients were enrolled. Male patients had a higher prevalence of pulmonary hypertension (33.0% vs 20.6%, p = 0.014), overall cancer (14.4% vs 6.7%, p = 0.006), and radiological usual interstitial pneumonia (UIP, 28.0% vs 16.2%, p = 0.003). They also had higher usage of antifibrotic drugs (24.8% vs 16.2%, p = 0.027). In contrast, female patients had higher positive rates for antinuclear antibody (83.6% vs 73.6%, p = 0.011) and anti-Ro52 antibody (59.8% vs 44.8%, p = 0.003). No differences existed in the total ESSDAI score between male and female patients. Follow-up data showed that male patients had higher 3-year (32.3% vs 18.0%, p = 0.003) and 5-year mortality (52.4% vs 35.0%, p = 0.006) compared to female patients. Multivariate Cox model indicated that age (HR 1.058, p < 0.001) and UIP (HR 1.874, p = 0.009) were significant prognostic factors.
Conclusions:
In pSjD-ILD, male patients tend to have more severe pulmonary manifestations, higher frequencies of pulmonary hypertension and cancer, and poorer outcomes compared to female patients. Key points • Male pSjD-ILD patients were more likely to suffer from pulmonary hypertension and cancer than their female counterparts. • Radiological UIP pattern was more frequently observed in male patients with pSjD-ILD than in female patients. • Male patients with pSjD-ILD had higher 3-year and 5-year mortality than female patients.
More Related Videos
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
07:25Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
Published on: October 13, 2023
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: